Mostrando 3 resultados de: 3
Filtros aplicados
Área temáticas
Enfermedades(3)
Farmacología y terapéutica(3)
Problemas sociales y servicios a grupos(2)
Medicina y salud(1)
Origen
scopus(3)
Coronavirus disease 2019 in Latin American patients with multiple sclerosis
OtherAbstract: Patients with multiple sclerosis (MS) who present coronavirus disease 2019 (COVID-19) are of particuPalabras claves:covid-19, Multiple Sclerosis, ocrelizumab, pandemic, rituximabAutores:Carcamo Rodriguez C., Carmisciano L., Ciampi E., Edgar Patricio Correa, Fragoso Y.D., Gomes S., Pimentel M.L.V., Ponzano M., Santos G.A.C., Schiavetti I., Sormani M.P., Steinberg J., Treviño-Frenk I., Vecino M.C.A., Vrech C., Winckler T.C.A.Fuentes:scopusImpact of Rituximab on relapse rate and disability in an Ecuadorian cohort of patients with neuromyelitis optica spectrum disorders
ArticleAbstract: Background: Neuromyelitis Optica Spectrum Disorder (NMOSD) is a severe inflammatory demyelinating diPalabras claves:anti-CD20 monoclonal antibody, B-cells, Ecuadorian NMOSD patients, neuromyelitis optica spectrum disorders, rituximabAutores:Edgar Patricio Correa, Francisco José Caiza-Zambrano, Miño-Zambrano J.E., Torres-Herrán G.E., Víctor P.G.Fuentes:scopusTherapeutic strategies in NMOSD and MOGAD patients: A multicenter cohort study in Latin America
ArticleAbstract: Purpose: This study describes the therapeutic strategies in NMOSD and MOGAD adopted by neurologistsPalabras claves:Latin America, MOGAD, NMOSD, rituximab, STRATEGIES, TherapeuticAutores:Alonso R., Becker J., Bribiesca Contreras E., Caride A., Castillo I.S.d., Contentti E.C., Criniti J.M., Cristiano E., Daccach Marques V., Edgar Patricio Correa, Flores-Rivera J., Galleguillos L., Gómez-Figueroa E., Gracia F., Hamuy F.D.d.B., Jefferson Santiago Piedra-Andrade, Lana-Peixoto M.A., López P.A., Man F., María Angélica Ortiz-Yépez, Nadur D., Navas C., Patrucco L., Pettinicchi J.P., Rojas J.I., Soares Neto H.R., Tkachuk V., Toral-Granda A.M., Wilson Alfredo Gualotuña PachacamaFuentes:scopus